Stoke Therapeutics Inc (STOK) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $35.55
• Market Cap: $2.03B
• P/E Ratio: 52.21
• EPS: $0.68
• 52-Week High: $38.69
• 52-Week Low: $5.35

Market Sentiment

Stoke Therapeutics Inc currently has a Bullish sentiment score of 0.37.

About Stoke Therapeutics Inc

Stoke Therapeutics, Inc. is a leading biopharmaceutical company dedicated to pioneering antisense oligonucleotide (ASO) therapies that tackle the underlying causes of severe genetic disorders. Headquartered in Bedford, Massachusetts, Stoke utilizes its proprietary technology platform to design and enhance ASOs, demonstrating a robust commitment to advancing genetic medicine. With its innovative approach and ongoing research and development initiatives, the company is well-positioned to transf...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Stoke Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does STOK pay dividends?

Stoke Therapeutics Inc (STOK) does not currently pay a regular dividend.

What is STOK's P/E ratio?

Stoke Therapeutics Inc has a price-to-earnings (P/E) ratio of 52.21.

What is STOK's market cap?

Stoke Therapeutics Inc (STOK) has a market capitalization of $2.03B with a current stock price of $35.55.